Modelling ALS and FTD

with human iPSC-derived neurons

 

Consistent, defined and scalable human iPSC-derived disease models for ALS and FTD research and drug discovery

Powered by opti-ox™ 

 

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are closely related progressive and fatal neurodegenerative conditions for which there is no cure. One of the biggest challenges slowing down the pace of ALS and FTD drug discovery research is the lack of consistent, physiologically relevant human cell models that accurately represent disease phenotypes and human pathophysiology in vitro.

We have developed ioDisease Model Cells™ with the aim of solving these challenges. Drug discovery experts can access human iPSC-derived neurons engineered with mutations commonly associated with ALS and FTD. Our TDP-43 and MAPT disease models show disease-related phenotypes of reduced neuronal activity and hyperphosphorylation respectively, when compared to a genetically matched control. ioDisease Model Cells are defined, consistent, and scalable, supporting translational research for the identification of new therapeutics that could halt or reverse the devastating effects of ALS and FTD.

Discover our ioDisease Model Cells for ALS and FTD research and drug discovery below.

ALS disease models in ioGlutamatergic Neurons 

ioGlutamatergic Neurons TDP‑43 M337V/WT™ ioDisease Model Cells
ioGlutamatergic Neurons TDP‑43 M337V/WT™ cat no. ioEA1006
Order now
ioGlutamatergic Neurons TDP‑43 M337V/M337V™ ioDisease Model Cells
ioGlutamatergic Neurons TDP‑43 M337V/M337V™ cat no. ioEA1005
Order now

FTD disease models in ioGlutamatergic Neurons

ioGlutamatergic Neurons MAPT P301S/WT™ ioDisease Model Cells
ioGlutamatergic Neurons MAPT P301S/WT™ cat no. io1015
Order now
ioGlutamatergic Neurons MAPT P301S/P301S™ ioDisease Model Cells
ioGlutamatergic Neurons MAPT P301S/P301S™ cat no. io1018
Order now
ioGlutamatergic Neurons MAPT N279K/WT™ ioDisease Model Cells
ioGlutamatergic Neurons MAPT N279K/WT™ cat no. io1009
Order now
ioGlutamatergic Neurons MAPT N279K/N279K™ ioDisease Model Cells
ioGlutamatergic Neurons MAPT N279K/N279K™ cat no. io1014
Order now

Pair ioDisease Model Cells with a genetically matched control

ioGlutamatergic Neurons™ ioWild Type Cells
ioGlutamatergic Neurons™ cat no. io1001
Order now

Generate your own ALS and FTD-related gene knockouts with ioCRISPR-Ready Cells™ 

Model any knockout mutation related to ALS and FTD with ioCRISPR-Ready Cells. These cells have Cas9 constitutively expressed, enabling scientists to easily generate gene knockouts in physiologically relevant cells in a matter of days.

ioGlutamatergic-Neurons-CRISPR-Ready-Hero-Image square

Don’t see what you’re looking for? Partner with us to generate custom ALS and FTD ioDisease Model Cells

Access our platform to generate custom disease model cells to answer your drug discovery and disease research questions.

Giving you easy access to the best cells-1

Related pages

Discover ioCells Learn about our range of human iPSC-derived cells for research and drug discovery
Resources Explore our latest scientific insights, webinars, blogs and videos
Our platform Discover the cell identity coding platform behind our cells